Nilotinib-induced psoriasis in a patient of chronic myeloid leukemia responding to methotrexate

被引：4
|
作者：
Kaur, Sukhjot [1 ]
Arora, Amanjot Kaur [1 ]
Sekhon, Jagdev S. [2 ]
Sood, Neena [3 ]
机构：
[1] Dayanand Med Coll & Hosp, Dept Dermatol & Venereol, Div Oncol, Ludhiana, Punjab, India
[2] Dayanand Med Coll & Hosp, Dept Internal Med, Div Oncol, Ludhiana, Punjab, India
[3] Dayanand Med Coll & Hosp, Dept Pathol, Ludhiana, Punjab, India
来源：
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY | 2015年 / 81卷 / 02期
关键词：
REGULATORY T-CELLS; GASTROINTESTINAL STROMAL TUMOR; CHRONIC MYELOGENOUS LEUKEMIA; IMATINIB-RESISTANT; PROLIFERATION; PATHOGENESIS; MANAGEMENT; INHIBITORS; DASATINIB;
D O I：
10.4103/0378-6323.152311
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：216 / 218
页数：3
相关论文
共 50 条
  • [1] Nilotinib-induced hypothyroidism in a patient with chronic myeloid leukemia
    Tetsuichi Yoshizato
    Yasuhito Nannya
    Yumiko Yoshiki
    Fumihiko Nakamura
    Yoichi Imai
    Motoshi Ichikawa
    Mineo Kurokawa
    International Journal of Hematology, 2011, 93 : 400 - 402
  • [2] Nilotinib-induced hypothyroidism in a patient with chronic myeloid leukemia
    Yoshizato, Tetsuichi
    Nannya, Yasuhito
    Yoshiki, Yumiko
    Nakamura, Fumihiko
    Imai, Yoichi
    Ichikawa, Motoshi
    Kurokawa, Mineo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (03) : 400 - 402
  • [3] Nilotinib-Induced Elephantine Psoriasis In a Patient With Chronic Myeloid Leukemia: A Rare Case Report and Literature Review
    Sadatmadani, Seyedeh Fatemeh
    Malakoutikhah, Zahra
    Mohaghegh, Fatemeh
    Peikar, Mohammadsaleh
    Saboktakin, Mahdi
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2022, 96
  • [4] Nilotinib-Induced Dystonia and Cognitive Deficits in a Neurologically Normal Patient with Chronic Myeloid Leukemia
    Chan, Justine
    Shah, Paarth
    Moguel-Cobos, Guillermo
    CASE REPORTS IN NEUROLOGICAL MEDICINE, 2019, 2019
  • [5] Nilotinib-Induced Diabetes Mellitus in a Young Female with Chronic Myeloid Leukemia
    Ismail, Abdel-Latif S.
    Yassin, Mohamed A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [6] Association between nilotinib-induced hyperbilirubinemia and UGT1A1 polymorphisms in a chronic myeloid leukemia patient
    Alarcon-Payer, Carolina
    Suarez, Maria Del Mar Sanchez
    Roldan, Alicia Martin
    Morales, Alberto Jimnez
    ANTI-CANCER DRUGS, 2025, 36 (05) : 438 - 439
  • [7] Nilotinib-induced panniculitis in a patient with chronic myelogenous leukaemia
    Kitayama, N.
    Otsuka, A.
    Hamamoto, C.
    Kaku, Y.
    Shiragami, H.
    Okumura, Y.
    Tsujioka, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (09)
  • [8] Imatinib- and Nilotinib-Induced Lichenoid Eruption in Chronic Myeloid Leukemia: A Rare Case Report
    Sachdeva, Meenakshi
    Singh, Jayanti
    Dayal, Surabhi
    Gupta, Aanchal
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2024, 15 (03) : 492 - 495
  • [9] Spontaneous recovery of severe nilotinib-induced bone marrow aplasia and successful retreatment with dasatinib in a patient with Chronic Phase Chronic Myeloid Leukemia
    Estephan, Fayez
    Rogers, Heesun J.
    Visconte, Valeria
    Tabarroki, Ali
    Ai, Jing
    Duong, Hien K.
    Kalaycio, Matt
    Tiu, Ramon V.
    LEUKEMIA & LYMPHOMA, 2015, 56 (03) : 811 - 813
  • [10] Total psoriasis regression in a patient with chronic myeloid leukemia treated using nilotinib
    Hornak, Tomas
    Zackova, Daniela
    Mayer, Jiri
    ANNALS OF HEMATOLOGY, 2025, : 2001 - 2004
12345